KemPharm, Inc. Soared
Thu, Jan 09, 2020 at 05:30 PM
KemPharm, Inc. (KMPH:NASDAQ) rocketted at $0.67, a gain of 31.7%. On Wed 08 Jan 20, KMPH:NASDAQ hit a New 2-Week Intraday High of $0.54. The stock got featured on our News Catalysts scanner on Thu 26 Dec 19 at 12:29 PM in the 'AGREEMENT' category. From Tue 17 Dec 19, the stock recorded 50.00% Up Days and 40.00% Green Days
About KemPharm, Inc. (KMPH:NASDAQ)
KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 122.84%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 93.96%
- Genetic Technologies Limited (GENE:NASDAQ), 45.09%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 36.53%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 35.71%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 34.96%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.71%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 33.59%
- KemPharm, Inc. (KMPH:NASDAQ), 31.72%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%